ChemoPower is awarded the Technology Enterprise Commercialisation Scheme by SPRING

ChemoPower is pleased to announce that we are awarded the maximum grant under the Technology Enterprise Commercialisation Scheme. This recognition from SPRING is indeed a strong validation of our company’s vision and the strong potential of our disruptive technology for the Traditional Medicines Industry.